Topics

Neptune Reveals Acasti Share Sale After Failed Drug Study

18:30 EST 14 Jan 2020 | Investing News Network

Neptune said the months-long sale generated US$4 million in net proceeds, a move geared at monetizing the firm’s non-core investments.

The post Neptune Reveals Acasti Share Sale After Failed Drug Study appeared first on Investing News Network.

Original Article: Neptune Reveals Acasti Share Sale After Failed Drug Study

NEXT ARTICLE

More From BioPortfolio on "Neptune Reveals Acasti Share Sale After Failed Drug Study"

Quick Search